Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29:1207-1212
Published online before print May 21, 2009, doi: 10.1161/ATVBAHA.109.184135
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
29/8/1207    most recent
ATVBAHA.109.184135v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Bellis, A.
Right arrow Articles by Morisco, C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bellis, A.
Right arrow Articles by Morisco, C.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29:1207.)
© 2009 American Heart Association, Inc.


Cell Biology/Signaling

Cross-Talk Between PKA and Akt Protects Endothelial Cells From Apoptosis in the Late Ischemic Preconditioning

Alessandro Bellis; Diletta Castaldo; Valentina Trimarco; Maria Gaia Monti; Pierpaolo Chivasso; Junichi Sadoshima; Bruno Trimarco; Carmine Morisco

From the Dipartimento di Medicina Clinica, Scienze Cardiovascolari ed Immunologiche (A.B., D.C., M.G.M., P.C., B.T., C.M.), Dipartimento di Neuroscienze (V.T.), Università FEDERICO II, Napoli, Italy; and the Department of Cell Biology and Molecular Medicine (J.S.), New Jersey Medical School, Newark.

Correspondence to Carmine Morisco, MD, PhD, Dipartimento di Medicina Clinica, Scienze Cardiovascolari ed Immunologiche. Università FEDERICO II, Napoli, Via S. Pansini n.5, 80131 Napoli, Italy. E-mail cmorisco{at}yahoo.com

Objective— The aim of this study was to explore the molecular mechanisms involved in late preconditioning-induced cell protection in endothelial cells.

Methods and Results— Preconditioning (PC) was induced by exposing bovine aortic endothelial cells (BAECs) to 3 cycles of 15 minutes of hypoxia followed by 15 minutes of reoxygenation. A 12-hour period of hypoxia induced cell death in 60% of BAECs (48±5% apoptosis, 12±4% necrosis). Early and late PC decreased hypoxia-induced apoptotic (25±5% and 28±4%, respectively) and necrotic (6±3%, and 8±2%, respectively) cell death. Consistently, hypoxia-induced caspase-3 cleavage was reduced by PC. Pretreatment with H89 (protein kinase A [PKA] inhibitor), LY294002 (phosphatidyl-inositol-3-kinase [PI3K] inhibitor), and N-acetyl-cysteine (antioxidant) abrogated late PC-induced cell protection, whereas inhibition of protein kinase C by Go6983, and of nitric oxide synthesis by L-NAME,1400W and bovine eNOS siRNA did not. In addition, in early and late PC, PKA physically interacted with the phosphorylated form of Akt, suggesting that PKA is required for Akt phosphorylation. Expression of PKA and Akt dominant negative mutants inhibited ischemic late PC-induced protection, indicating that these kinases play a key role in late PC-mediated cell protection.

Conclusions— Late ischemic PC protects BAECs against hypoxia through PKA- and PI3K-dependent activation of Akt.

We explored the molecular mechanisms involved in late preconditioning (PC)-induced protection of endothelial cells. Late PC protects endothelial cells from hypoxia-induced cell death through protein kinase A- and phosphatidyl-inositol-3-kinase-dependent mechanisms. Both pathways account for late PC-induced activation of Akt, which plays a critical role in PC-mediated cytoprotection.


Key Words: hypoxia • phosphatidyl-inositol-3-kinase • caspase-3 • nitric oxide • cell protection